134 related articles for article (PubMed ID: 9682388)
1. IgA antibody-forming cell responses in the nasal-associated lymphoid tissue of mice vaccinated by intranasal, intravenous and/or subcutaneous administration.
Asanuma H; Aizawa C; Kurata T; Tamura S
Vaccine; 1998 Aug; 16(13):1257-62. PubMed ID: 9682388
[TBL] [Abstract][Full Text] [Related]
2. Immune responses and protection in different strains of aged mice immunized intranasally with an adjuvant-combined influenza vaccine.
Asanuma H; Hirokawa K; Uchiyama M; Suzuki Y; Aizawa C; Kurata T; Sata T; Tamura S
Vaccine; 2001 Jul; 19(28-29):3981-9. PubMed ID: 11427274
[TBL] [Abstract][Full Text] [Related]
3. Cytokine mRNAs in the nasal-associated lymphoid tissue during influenza virus infection and nasal vaccination.
Matsuo K; Iwasaki T; Asanuma H; Yoshikawa T; Chen Z; Tsujimoto H; Kurata T; Tamura SS
Vaccine; 2000 Jan; 18(14):1344-50. PubMed ID: 10618531
[TBL] [Abstract][Full Text] [Related]
4. Antibody-forming cells in the nasal-associated lymphoid tissue during primary influenza virus infection.
Tamura S; Iwasaki T; Thompson AH; Asanuma H; Chen Z; Suzuki Y; Aizawa C; Kurata T
J Gen Virol; 1998 Feb; 79 ( Pt 2)():291-9. PubMed ID: 9472613
[TBL] [Abstract][Full Text] [Related]
5. Characterization of protective immune responses induced by nasal influenza vaccine containing mutant cholera toxin as a safe adjuvant (CT112K).
Watanabe I; Hagiwara Y; Kadowaki SE; Yoshikawa T; Komase K; Aizawa C; Kiyono H; Takeda Y; McGhee JR; Chiba J; Sata T; Kurata T; Tamura S
Vaccine; 2002 Oct; 20(29-30):3443-55. PubMed ID: 12297389
[TBL] [Abstract][Full Text] [Related]
6. Induction of innate immunity by nasal influenza vaccine administered in combination with an adjuvant (cholera toxin).
Matsuo K; Yoshikawa T; Asanuma H; Iwasaki T; Hagiwara Y; Chen Z; Kadowaki SE; Tsujimoto H; Kurata T; Tamura SI
Vaccine; 2000 Jun; 18(24):2713-22. PubMed ID: 10781859
[TBL] [Abstract][Full Text] [Related]
7. Cross-protection against influenza virus infection in mice vaccinated by combined nasal/subcutaneous administration.
Asanuma H; Koide F; Suzuki Y; Nagamine T; Aizawa C; Kurata T; Tamura S
Vaccine; 1995 Jan; 13(1):3-5. PubMed ID: 7762274
[TBL] [Abstract][Full Text] [Related]
8. Anti-TNP-forming cells in rats after different routes of priming with TNP-LPS followed by intranasal boosting with the same antigen.
Hameleers DM; van der Ven I; Sminia T; Biewenga J
Res Immunol; 1990; 141(6):515-28. PubMed ID: 2284497
[TBL] [Abstract][Full Text] [Related]
9. Intranasal immunization with polymer-grafted microparticles activates the nasal-associated lymphoid tissue and draining lymph nodes.
Heritage PL; Brook MA; Underdown BJ; McDermott MR
Immunology; 1998 Feb; 93(2):249-56. PubMed ID: 9616375
[TBL] [Abstract][Full Text] [Related]
10. Intranasal vaccination of infant mice induces protective immunity in the absence of nasal-associated lymphoid tissue.
Sabirov A; Metzger DW
Vaccine; 2008 Mar; 26(12):1566-76. PubMed ID: 18281130
[TBL] [Abstract][Full Text] [Related]
11. TH cells primed during influenza virus infection provide help for qualitatively distinct antibody responses to subsequent immunization.
Marshall D; Sealy R; Sangster M; Coleclough C
J Immunol; 1999 Nov; 163(9):4673-82. PubMed ID: 10528164
[TBL] [Abstract][Full Text] [Related]
12. Development of antibody-secreting cells and antigen-specific T cells in cervical lymph nodes after intranasal immunization.
Wu HY; Nikolova EB; Beagley KW; Eldridge JH; Russell MW
Infect Immun; 1997 Jan; 65(1):227-35. PubMed ID: 8975916
[TBL] [Abstract][Full Text] [Related]
13. Kinetics of mouse antibody and lymphocyte responses during intranasal vaccination with a lipooligosaccharide-based conjugate vaccine.
Hirano T; Jiao X; Chen Z; Van Waes C; Gu XX
Immunol Lett; 2006 Nov; 107(2):131-9. PubMed ID: 17030407
[TBL] [Abstract][Full Text] [Related]
14. Induction of Local Secretory IgA and Multifunctional CD4⁺ T-helper Cells Following Intranasal Immunization with a H5N1 Whole Inactivated Influenza Virus Vaccine in BALB/c Mice.
Trondsen M; Aqrawi LA; Zhou F; Pedersen G; Trieu MC; Zhou P; Cox RJ
Scand J Immunol; 2015 May; 81(5):305-17. PubMed ID: 25737202
[TBL] [Abstract][Full Text] [Related]
15. Antibody responses and protection in mice immunized orally against influenza virus.
Takase H; Murakami Y; Endo A; Ikeuchi T
Vaccine; 1996 Dec; 14(17-18):1651-6. PubMed ID: 9032895
[TBL] [Abstract][Full Text] [Related]
16. Comparative studies of local antibody and cellular immune responses to influenza infection and vaccination with live attenuated reassortant influenza vaccine (LAIV) utilizing a mouse nasal-associated lymphoid tissue (NALT) separation method.
Petukhova G; Naikhin A; Chirkova T; Donina S; Korenkov D; Rudenko L
Vaccine; 2009 Apr; 27(19):2580-7. PubMed ID: 19428864
[TBL] [Abstract][Full Text] [Related]
17. Protective antibody responses against A(H1N1)pdm09 primed by infection and recalled by intranasal vaccination.
Ikeda K; Ainai A; Hasegawa H
Vaccine; 2015 Nov; 33(45):6066-9. PubMed ID: 26432916
[TBL] [Abstract][Full Text] [Related]
18. Comparison of murine nasal-associated lymphoid tissue and Peyer's patches.
Heritage PL; Underdown BJ; Arsenault AL; Snider DP; McDermott MR
Am J Respir Crit Care Med; 1997 Oct; 156(4 Pt 1):1256-62. PubMed ID: 9351630
[TBL] [Abstract][Full Text] [Related]
19. Nasal lymphoid tissue (NALT) as a mucosal immune inductive site.
Wu HY; Nguyen HH; Russell MW
Scand J Immunol; 1997 Nov; 46(5):506-13. PubMed ID: 9393634
[TBL] [Abstract][Full Text] [Related]
20. Comparison of intranasal inoculation of influenza HA vaccine combined with cholera toxin B subunit with oral or parenteral vaccination.
Hirabayashi Y; Kurata H; Funato H; Nagamine T; Aizawa C; Tamura S; Shimada K; Kurata T
Vaccine; 1990 Jun; 8(3):243-8. PubMed ID: 2363302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
